World's First? AI Creates Biotech Company: FEESH Secures 1.36M DKK Funding

Danish AI platform and Nordic BioVentures pioneer a new frontier in biotech company creation, developing sustainable fish meal alternatives with AI.

  • World's First? AI Creates Biotech Company: FEESH Secures 1.36M DKK Funding
  • World's First? AI Creates Biotech Company: FEESH Secures 1.36M DKK Funding

Gentofte, Kobenhavn Feb 27, 2025 (Issuewire.com)  - In a likely world first event, artificial intelligence has moved beyond assisting business to actually creating one. Amass Technologies and Nordic BioVentures announces the successful inauguration and subsequent funding of FEESH, a revolutionary biotech company conceived and validated by AI. The company, which develops sustainable fish meal alternatives using fermented insects, has secured 1.36M DKK in funding from Denmark’s Innovation Fund and Det Arnstedtske Familiefond, who joined NBV in the seed round.

This breakthrough represents the first time an AI system has identified, validated, and specified the technical foundation for a life sciences company that has gone on to receive significant funding. FEESH was created using GEMA, Amass Technologies' advanced life sciences AI model, which analyzed vast datasets to identify high-impact opportunities in sustainable nutrition; curated by the subject matter experts at Nordic BioVentures.

"This marks a fundamental shift in how biotech companies can be created," said Henrik Jensen, CEO of Amass Technologies. "GEMA didn't just suggest an idea – it developed a complete technical framework for a viable solution to one of aquaculture's most pressing challenges. And importantly - in a biotech context - it passed the narrow test window in the lab, testing at scale, in the first go. Not to mention that our model "

The company's core innovation lies in its fermented insect-based protein, which delivers a nutritional profile comparable to traditional fish meal, offering a sustainable alternative for the aquaculture industry. This solution addresses both environmental concerns and the growing demand for sustainable protein sources.

Will Wright, Managing Partner at Nordic BioVentures, noted: "What makes this truly revolutionary is that the entire technical foundation – from the initial concept to the specific bioprocessing parameters – was developed by GEMA, assisted and vetted by our scientists along the way, and FEESH demonstrates that AI can now create companies that attract serious investment."

free




Media Contact

amass technologies aps hj@amass.tech 61715972 Nordre Fasanvej 215 http://www.amass.tech
Categories : Biotech , Science , Software , Technology
Tags : life science , biotech , biopharma , ai

Amass technologies aps

hj@amass.tech
Nordre Fasanvej 215

2000
+45 61715972
http://www.amass.tech
Report Spam